- Home
- SCD vs CMPX Comparison
SCD vs CMPX Comparison
Compare SCD & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCD
- CMPX
- Stock Information
- Founded
- SCD 2003
- CMPX 2014
- Country
- SCD United States
- CMPX United States
- Employees
- SCD N/A
- CMPX N/A
- Industry
- SCD Trusts Except Educational Religious and Charitable
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- SCD Finance
- CMPX Health Care
- Exchange
- SCD Nasdaq
- CMPX Nasdaq
- Market Cap
- SCD 264.7M
- CMPX 291.8M
- IPO Year
- SCD N/A
- CMPX N/A
- Fundamental
- Price
- SCD $15.78
- CMPX $3.73
- Analyst Decision
- SCD
- CMPX Strong Buy
- Analyst Count
- SCD 0
- CMPX 8
- Target Price
- SCD N/A
- CMPX $13.50
- AVG Volume (30 Days)
- SCD 62.6K
- CMPX 978.2K
- Earning Date
- SCD 01-01-0001
- CMPX 11-11-2025
- Dividend Yield
- SCD 9.63%
- CMPX N/A
- EPS Growth
- SCD N/A
- CMPX N/A
- EPS
- SCD N/A
- CMPX N/A
- Revenue
- SCD N/A
- CMPX N/A
- Revenue This Year
- SCD N/A
- CMPX N/A
- Revenue Next Year
- SCD N/A
- CMPX N/A
- P/E Ratio
- SCD N/A
- CMPX N/A
- Revenue Growth
- SCD N/A
- CMPX N/A
- 52 Week Low
- SCD $11.33
- CMPX $1.27
- 52 Week High
- SCD $15.87
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- SCD 70.59
- CMPX 72.61
- Support Level
- SCD $15.36
- CMPX $3.37
- Resistance Level
- SCD $15.80
- CMPX $3.70
- Average True Range (ATR)
- SCD 0.11
- CMPX 0.19
- MACD
- SCD 0.04
- CMPX 0.03
- Stochastic Oscillator
- SCD 93.48
- CMPX 98.53
About SCD LMP Capital and Income Fund Inc.
Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.